Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preliminary Human Study on Bioavailability and Efficacy of Bioactive Peptide IRW in Egg White Hydrolysate

NCT06555393 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT06555393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06555393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preliminary Human Study on Bioavailability and Efficacy of Bioactive Peptide IRW in Egg White Hydrolysate
Lead sponsor
University of Alberta
Phase
Phase 1
Overall status
Recruiting
Start date
February 25, 2026
Completion date
October 31, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high blood pressure, high blood sugar, overweight and obesity